TACT Meeting 2021
The TREAT-NMD Advisory Committee for Therapeutics (TACT) is a unique multi-disciplinary, international group of well recognized academic and industry drug development experts, as well as patients and/or patient representatives. TACT meets twice a year to review and provide guidance on the translation and development path of therapeutics programs in rare neuromuscular diseases with large unmet need. The confidential and comprehensive review provides recommendations including go-no-go milestones, is independent of any funding stream however it may enable subsequent funding. TACT invites applications for advice from both industry and academia. If you would like to know more about TACT or would like to submit an application, please contact Cathy Turner.